← Back to Search

Other

Platelet-Rich Plasma for Erectile Dysfunction

Phase 1

Waitlist Available

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Males between >30 and <70 years of age with erectile dysfunction (ED) based on IIEF scores (score between 16 and 25)

Be older than 18 years old

Must not have

Anatomical malformation of the penis, including Peyronie's disease

Patient is taking blood thinners and has an international normalized ratio (INR) >3

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1, 3, 6 months post-procedure

Summary

"This trial is looking at different therapies like platelet-rich plasma injections, shockwave therapy, and stem cell therapy for erectile dysfunction. While these treatments are non-invasive, there is still limited data on

Who is the study for?

This trial is for men experiencing erectile dysfunction. Participants should be seeking a non-invasive treatment option and have not found success with other therapies. Specific eligibility criteria are not provided, but typically include age range, health status, and the severity of ED.

What is being tested?

The study is testing the effectiveness of Platelet-Rich-Plasma (PRP) injections compared to saline (a placebo) in treating erectile dysfunction. It's Canada's first pilot randomized controlled trial on PRP for ED, aiming to see if it can improve underlying tissue and nerve function.

What are the potential side effects?

While specific side effects are not listed here, PRP generally has minimal side effects since it uses the patient’s own blood. However, potential risks may include pain at injection site, infection or no improvement in ED symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a man aged 31-69 with mild to moderate erectile dysfunction.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a physical deformity of my penis.

Select...

I am on blood thinners with an INR greater than 3.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1, 3, 6 months post-procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1, 3, 6 months post-procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6 months post-procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

International Index of Erectile Function (IIEF)

Secondary study objectives

Adverse Events

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Platelet-Rich-Plasma (PRP)Experimental Treatment1 Intervention

PRP refers to a treatment where a patient's own blood is used to promote healing. Blood is drawn, processed to concentrate the platelets, and then re-injected into the injured area to stimulate tissue repair.

Group II: SalinePlacebo Group1 Intervention

Provider will go through the same motions as injecting PRP, but will use saline instead which has no known effect.

0 / 3Eligibility criteria met